Cibc World Markets Corp Purchases 1,317 Shares of Waters Co. (NYSE:WAT)

Cibc World Markets Corp boosted its stake in Waters Co. (NYSE:WAT - Free Report) by 16.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,373 shares of the medical instruments supplier's stock after purchasing an additional 1,317 shares during the period. Cibc World Markets Corp's holdings in Waters were worth $3,477,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Bank of Jackson Hole Trust bought a new stake in shares of Waters in the fourth quarter worth $34,000. Fortitude Family Office LLC grew its stake in shares of Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 66 shares during the period. Steward Partners Investment Advisory LLC increased its position in shares of Waters by 129.3% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 53 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Waters by 54.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock worth $46,000 after purchasing an additional 44 shares during the period. Finally, R Squared Ltd purchased a new position in shares of Waters in the fourth quarter worth approximately $63,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Price Performance

Waters stock traded down $5.09 during mid-day trading on Tuesday, reaching $368.21. 456,859 shares of the company's stock traded hands, compared to its average volume of 440,020. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56. The company has a market cap of $21.88 billion, a price-to-earnings ratio of 34.38, a PEG ratio of 3.79 and a beta of 1.00. The stock has a 50 day moving average of $390.29 and a two-hundred day moving average of $371.85. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14.

Remove Ads

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts' consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Equities analysts forecast that Waters Co. will post 12.86 earnings per share for the current year.

Analyst Upgrades and Downgrades

WAT has been the topic of several recent research reports. Scotiabank upgraded shares of Waters from a "sector perform" rating to a "sector outperform" rating and increased their price target for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. StockNews.com cut Waters from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Barclays upgraded Waters from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. Wells Fargo & Company lifted their price objective on Waters from $415.00 to $420.00 and gave the company an "overweight" rating in a research report on Thursday, February 13th. Finally, UBS Group increased their price objective on shares of Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a research note on Thursday, February 13th. Eleven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $391.07.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.